{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:28:00Z","timestamp":1788974880443,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-025-00560-3","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T03:24:27Z","timestamp":1744082667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stearyl amine tailored spanlastics embedded within tetronic\u00ae nanogel for boosting the repurposed anticancer potential of mebendazole: formulation, in vitro profiling, cytotoxicity assessment, and in vivo permeation analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Mai","family":"El Halawany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Sharaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"560_CR1","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.3390\/molecules28135145","volume":"28","author":"M Xu","year":"2023","unstructured":"Xu M, Han X, Xiong H, Gao Y, Xu B, Zhu G, Li J. Cancer nanomedicine: emerging strategies and therapeutic potentials. Molecules. 2023;28:5145. https:\/\/doi.org\/10.3390\/molecules28135145.","journal-title":"Molecules"},{"key":"560_CR2","doi-asserted-by":"publisher","first-page":"205031212110343","DOI":"10.1177\/20503121211034366","volume":"9","author":"DT Debela","year":"2021","unstructured":"Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, Kitui SK, Manyazewal T. New approaches and procedures for cancer treatment: Current perspectives. SAGE open med. 2021;9:20503121211034370. https:\/\/doi.org\/10.1177\/20503121211034366.","journal-title":"SAGE open med"},{"key":"560_CR3","first-page":"1","volume":"1","author":"J Mondal","year":"2014","unstructured":"Mondal J, Panigrahi A, Khuda-Bukhsh A. Conventional chemotherapy: problems and scope for combined therapies with certain herbal products and dietary supplements. Austin J Mol Cell Biol. 2014;1:1\u201310.","journal-title":"Austin J Mol Cell Biol"},{"key":"560_CR4","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.2174\/0929867325666180713155702","volume":"26","author":"S Olgen","year":"2019","unstructured":"Olgen S, Kotra LP. Drug repurposing in the development of anticancer agents. Curr med chem. 2019;26:5410\u201327. https:\/\/doi.org\/10.2174\/0929867325666180713155702.","journal-title":"Curr med chem"},{"key":"560_CR5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13:714\u201326. https:\/\/doi.org\/10.1038\/nrc3599.","journal-title":"Nat Rev Cancer"},{"key":"560_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C. Drug repurposing: progress, challenges and recommendations. Nat rev Drug discov. 2019;18:41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168.","journal-title":"Nat rev Drug discov"},{"key":"560_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bios.2016.04.081","volume":"85","author":"H Shashaani","year":"2016","unstructured":"Shashaani H, Faramarzpour M, Hassanpour M, Namdar N, Alikhani A, Abdolahad M. Silicon nanowire based biosensing platform for electrochemical sensing of Mebendazole drug activity on breast cancer cells. Biosens Bioelectron. 2016;85:363\u201370. https:\/\/doi.org\/10.1016\/j.bios.2016.04.081.","journal-title":"Biosens Bioelectron"},{"key":"560_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13058-022-01591-3","volume":"24","author":"NS Joe","year":"2022","unstructured":"Joe NS, Godet I, Milki N, Ain NU, Oza HH, Riggins GJ, Gilkes DM. Mebendazole prevents distant organ metastases in part by decreasing ITG\u03b24 expression and cancer stemness. Breast Cancer Res. 2022;24:98. https:\/\/doi.org\/10.1186\/s13058-022-01591-3.","journal-title":"Breast Cancer Res"},{"key":"560_CR9","first-page":"1201","volume":"1","author":"J-I Sasaki","year":"2002","unstructured":"Sasaki J-I, Ramesh R, Chada S, Gomyo Y, Roth JA, Mukhopadhyay T. The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells. Mol Cancer Ther. 2002;1:1201\u20139.","journal-title":"Mol Cancer Ther"},{"key":"560_CR10","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-14-2681","volume":"21","author":"R-Y Bai","year":"2015","unstructured":"Bai R-Y, Staedtke V, Wanjiku T, Rudek MA, Joshi A, Gallia GL, Riggins GJ. Brain penetration and efficacy of different mebendazole polymorphs in a mouse brain tumor model. Clin Cancer Res. 2015;21:3462\u201370. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2681.","journal-title":"Clin Cancer Res"},{"key":"560_CR11","doi-asserted-by":"publisher","first-page":"68571","DOI":"10.18632\/oncotarget.11851","volume":"7","author":"T Williamson","year":"2016","unstructured":"Williamson T, Bai R-Y, Staedtke V, Huso D, Riggins GJ. Mebendazole and a non-steroidal antiinflammatory combine to reduce tumor initiation in a colon cancer preclinical model. Oncotarget. 2016;7:68571\u201384. https:\/\/doi.org\/10.18632\/oncotarget.11851.","journal-title":"Oncotarget"},{"key":"560_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijrobp.2018.08.046","volume":"103","author":"L Zhang","year":"2019","unstructured":"Zhang L, Dratver MB, Yazal T, Dong K, Nguyen A, Yu G, Dao A, Dratver MB, Duhachek-Muggy S, Bhat K. Mebendazole potentiates radiation therapy in triple-negative breast cancer. Int J Rad Oncol Biol Phys. 2019;103:195\u2013207. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.08.046.","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"560_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/ITT.S134842","volume":"7","author":"B Domingues","year":"2018","unstructured":"Domingues B, Lopes JM, Soares P, P\u00f3pulo H. Melanoma treatment in review. ImmunoTarget Ther. 2018;7:35\u201349. https:\/\/doi.org\/10.2147\/ITT.S134842.","journal-title":"ImmunoTarget Ther"},{"key":"560_CR14","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1038\/sj.onc.1206454","volume":"22","author":"MS Soengas","year":"2003","unstructured":"Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene. 2003;22:3138\u201351. https:\/\/doi.org\/10.1038\/sj.onc.1206454.","journal-title":"Oncogene"},{"key":"560_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12951-022-01380-2","volume":"20","author":"A Kefayat","year":"2022","unstructured":"Kefayat A, Hosseini M, Ghahremani F, Jolfaie NA, Rafienia M. Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded\/folic acidtargeted chitosan nanoparticles for murine triple-negative breast cancer treatment. J Nanobiotechnology. 2022;20:169. https:\/\/doi.org\/10.1186\/s12951-022-01380-2.","journal-title":"J Nanobiotechnology"},{"key":"560_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105276","volume":"91","author":"RD Patel","year":"2024","unstructured":"Patel RD, Patel AS, Patel HJ, Sarvepalli S, Patel K. Development of rapidly soluble mebendazole nanosuspension for colorectal cancer. J Drug Deliv Sci Technol. 2024;91: 105276. https:\/\/doi.org\/10.1016\/j.jddst.2023.105276.","journal-title":"J Drug Deliv Sci Technol"},{"key":"560_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/02726351.2020.1750515","volume":"39","author":"S Shrivastava","year":"2021","unstructured":"Shrivastava S, Gidwani B, Kaur CD. Development of mebendazole loaded nanostructured lipid carriers for lymphatic targeting: Optimization, characterization, in-vitro and in-vivo evaluation. Particul Sci Technol. 2021;39:380\u201390. https:\/\/doi.org\/10.1080\/02726351.2020.1750515.","journal-title":"Particul Sci Technol"},{"key":"560_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.7324\/JAPS.2023.110512","volume":"13","author":"M Kutkut","year":"2023","unstructured":"Kutkut M, Shakya AK, Nsairat H, El-Tanani M. Formulation, development, and in vitro evaluation of a nanoliposomal delivery system for mebendazole and gefitinib. J Applied Pharma Sci. 2023;13:165\u201378. https:\/\/doi.org\/10.7324\/JAPS.2023.110512.","journal-title":"J Applied Pharma Sci"},{"key":"560_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1208\/s12249-019-1306-2","volume":"20","author":"AM Fahmy","year":"2019","unstructured":"Fahmy AM, El-Setouhy DA, Habib BA, Tayel SA. Enhancement of transdermal delivery of haloperidol via spanlastic dispersions: entrapment efficiency vs particle size. AAPS PharmSciTech. 2019;20:95. https:\/\/doi.org\/10.1208\/s12249-019-1306-2.","journal-title":"AAPS PharmSciTech"},{"key":"560_CR20","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3109\/10717544.2014.942811","volume":"23","author":"AN ElMeshad","year":"2016","unstructured":"ElMeshad AN, Mohsen AM. Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle. Drug Deliv. 2016;23:2115\u201323. https:\/\/doi.org\/10.3109\/10717544.2014.942811.","journal-title":"Drug Deliv"},{"key":"560_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijpharm.2011.03.049","volume":"411","author":"A Gillet","year":"2011","unstructured":"Gillet A, Comp\u00e8re P, Lecomte F, Hubert P, Ducat E, Evrard B, Piel G. Liposome surface charge influence on skin penetration behaviour. Int J Pharm. 2011;411:223\u201331. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.03.049.","journal-title":"Int J Pharm"},{"key":"560_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jconrel.2015.11.009","volume":"240","author":"KS Soni","year":"2016","unstructured":"Soni KS, Desale SS, Bronich TK. Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation. J Control Release. 2016;240:109\u201326. https:\/\/doi.org\/10.1016\/j.jconrel.2015.11.009.","journal-title":"J Control Release"},{"key":"560_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jconrel.2017.03.023","volume":"253","author":"P Sahu","year":"2017","unstructured":"Sahu P, Kashaw SK, Jain S, Sau S, Iyer AK. Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: In vitro and ex vivo studies. J Control Release. 2017;253:122\u201336. https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.023.","journal-title":"J Control Release"},{"key":"560_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.colsurfb.2018.11.018","volume":"174","author":"P Sahu","year":"2019","unstructured":"Sahu P, Kashaw SK, Sau S, Kushwah V, Jain S, Agrawal RK, Iyer AK. pH Responsive 5-fluorouracil loaded biocompatible nanogels for topical chemotherapy of aggressive melanoma. Colloids Surf B Biointerfaces. 2019;174:232\u201345. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.11.018.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"560_CR25","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/j.actbio.2012.03.003","volume":"8","author":"E Cho","year":"2012","unstructured":"Cho E, Lee JS, Webb K. Formulation and characterization of poloxamine-based hydrogels as tissue sealants. Acta Biomater. 2012;8:2223\u201332. https:\/\/doi.org\/10.1016\/j.actbio.2012.03.003.","journal-title":"Acta Biomater"},{"key":"560_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2023.100201","volume":"6","author":"OA Agha","year":"2023","unstructured":"Agha OA, Girgis GNS, El-Sokkary MMA, Soliman OAE. Spanlastic-laden in situ gel as a promising approach for ocular delivery of Levofloxacin: In-vitro characterization, microbiological assessment, corneal permeability and in-vivo study. Int J Pharm X. 2023;6: 100201. https:\/\/doi.org\/10.1016\/j.ijpx.2023.100201.","journal-title":"Int J Pharm X"},{"key":"560_CR27","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.3390\/pharmaceutics14081746","volume":"14","author":"D Aziz","year":"2022","unstructured":"Aziz D, Mohamed SA, Tayel S, Makhlouf A. Enhanced ocular anti-aspergillus activity of tolnaftate employing novel cosolvent-modified spanlastics: formulation, statistical optimization, kill kinetics, ex vivo trans-corneal permeation, in vivo histopathological and susceptibility study. Pharmaceutics. 2022;14:1746. https:\/\/doi.org\/10.3390\/pharmaceutics14081746.","journal-title":"Pharmaceutics"},{"key":"560_CR28","unstructured":"Parakh DR, Patil MP, Sonawane SS and Jain CP. Development and validation of spectrophotometric method for estimation of Mebendazole in bulk and pharmaceutical formulation. World j pharma res. 2015;4:2223\u201335. https:\/\/api.semanticscholar.org\/CorpusID:212610672."},{"key":"560_CR29","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1021\/acs.langmuir.6b01544","volume":"32","author":"R Serra-G\u00f3mez","year":"2016","unstructured":"Serra-G\u00f3mez R, Dreiss CA, Gonz\u00e1lez-Benito J, Gonz\u00e1lez-Gaitano G. Structure and rheology of poloxamine T1107 and its nanocomposite hydrogels with cyclodextrin-modified barium titanate nanoparticles. Langmuir. 2016;32:6398\u2013408. https:\/\/doi.org\/10.1021\/acs.langmuir.6b01544.","journal-title":"Langmuir"},{"key":"560_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/cosmetics8030069","volume":"8","author":"M Luki\u0107","year":"2021","unstructured":"Luki\u0107 M, Panteli\u0107 I, Savi\u0107 SD. Towards optimal ph of the skin and topical formulations: from the current state of the art to tailored products. Cosmetics. 2021;8:69. https:\/\/doi.org\/10.3390\/cosmetics8030069.","journal-title":"Cosmetics"},{"key":"560_CR31","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.13040\/ijpsr.0975-8232.12(4).2317-22","volume":"12","author":"S Shrivastava","year":"2021","unstructured":"Shrivastava S, Kaur CD. Development and validation of novel uv spectrophotometric method for the determination of mebendazole in pharmaceutical formulation. Int J Pharm Sci Res. 2021;12:2317\u201322. https:\/\/doi.org\/10.13040\/ijpsr.0975-8232.12(4).2317-22.","journal-title":"Int J Pharm Sci Res"},{"key":"560_CR32","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82:1107\u201312. https:\/\/doi.org\/10.1093\/jnci\/82.13.1107.","journal-title":"J Natl Cancer Inst"},{"key":"560_CR33","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1158\/1541-7786.Mcr-07-2159","volume":"6","author":"N Doudican","year":"2008","unstructured":"Doudican N, Rodriguez A, Osman I, Orlow SJ. Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells. Mol Cancer Res. 2008;6:1308\u201315. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-07-2159.","journal-title":"Mol Cancer Res"},{"key":"560_CR34","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Hurst V, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, W\u00fcrbel H. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biology. 2020;18:e3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411.","journal-title":"PLOS Biology"},{"key":"560_CR35","doi-asserted-by":"publisher","unstructured":"Francischi JN, Frade TIC, Almeida MPAd, Queiroz BFGd, Bakhle YS. Ketamine-xylazine anaesthesia and orofacial administration of substance P: A lethal combination in rats. Neuropeptides. 2017;62:21\u20136. https:\/\/doi.org\/10.1016\/j.npep.2017.01.003.","DOI":"10.1016\/j.npep.2017.01.003"},{"key":"560_CR36","doi-asserted-by":"publisher","unstructured":"Abdelbary AA, Abd-Elsalam WH, Al-Mahallawi AM. Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment. Int j pharm. 2016;513:688\u201396. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.10.006.","DOI":"10.1016\/j.ijpharm.2016.10.006"},{"key":"560_CR37","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cej.2010.11.062","volume":"166","author":"LS De Lima","year":"2011","unstructured":"De Lima LS, Araujo MDM, Quin\u00e1ia SP, Migliorine DW, Garcia JR. Adsorption modeling of Cr, Cd and Cu on activated carbon of different origins by using fractional factorial design. Chem Eng J. 2011;166:881\u20139. https:\/\/doi.org\/10.1016\/j.cej.2010.11.062.","journal-title":"Chem Eng J"},{"key":"560_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1081\/sl-100106868","volume":"34","author":"AA Bunaciu","year":"2001","unstructured":"Bunaciu AA, Fleschin S, Aboul-Enein HY. Analysis of mebendazole polymorphs by fourier transform infrared spectrometry using chemometric methods. Spectrosc Lett. 2001;34:527\u201336. https:\/\/doi.org\/10.1081\/sl-100106868.","journal-title":"Spectrosc Lett"},{"key":"560_CR39","unstructured":"Gunasekaran S and Uthra D. Vibrational Spectra and Qualitative Analysis of Albendazole and Mebendazole. Asian J Chem. 2008;20:6310\u20136324. https:\/\/api.semanticscholar.org\/CorpusID:54820619"},{"key":"560_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.103061","volume":"68","author":"CE Mary Dcruz","year":"2022","unstructured":"Mary Dcruz CE, Bhide PJ, Kumar L, Shirodkar RK. Novel nano spanlastic carrier system for buccal delivery of lacidipine. J Drug Deliv Sci Technol. 2022;68: 103061. https:\/\/doi.org\/10.1016\/j.jddst.2021.103061.","journal-title":"J Drug Deliv Sci Technol"},{"key":"560_CR41","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1039\/C2CE25724F","volume":"14","author":"J-M Chen","year":"2012","unstructured":"Chen J-M, Wang Z-Z, Wu C-B, Li S, Lu T-B. Crystal engineering approach to improve the solubility of mebendazole. CrystEngComm. 2012;14:6221\u20139. https:\/\/doi.org\/10.1039\/C2CE25724F.","journal-title":"CrystEngComm"},{"key":"560_CR42","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/cancers11091284","volume":"11","author":"AE Guerini","year":"2019","unstructured":"Guerini AE, Triggiani L, Maddalo M, Bonu ML, Frassine F, Baiguini A, Alghisi A, Tomasini D, Borghetti P, Pasinetti N, Bresciani R, Magrini SM, Buglione M. Mebendazole as a candidate for drug repurposing in oncology: an extensive review of current literature. Cancers (Basel). 2019;11:1284. https:\/\/doi.org\/10.3390\/cancers11091284.","journal-title":"Cancers (Basel)"},{"key":"560_CR43","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.2147\/DDDT.S265167","volume":"14","author":"F Badria","year":"2020","unstructured":"Badria F, Mazyed E. Formulation of Nanospanlastics as a Promising Approach for Improving the Topical Delivery of a Natural Leukotriene Inhibitor (3-Acetyl-11-Keto-beta-Boswellic Acid): Statistical Optimization, in vitro Characterization, and ex vivo Permeation Study. Drug Des Devel Ther. 2020;14:3697\u2013721. https:\/\/doi.org\/10.2147\/DDDT.S265167.","journal-title":"Drug Des Devel Ther"},{"key":"560_CR44","doi-asserted-by":"publisher","unstructured":"Aziz DE, Abdelbary AA, Elassasy AI. Implementing central composite design for developing transdermal diacerein-loaded niosomes: Ex vivo permeation and in vivo deposition. Current drug deliv. 2018;15:1330\u201342. https:\/\/doi.org\/10.2174\/1567201815666180619105419.","DOI":"10.2174\/1567201815666180619105419"},{"key":"560_CR45","doi-asserted-by":"publisher","unstructured":"El Menshawe SF, Nafady MM, Aboud HM, Kharshoum RM, Elkelawy A, Hamad DS. Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund's adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway. Drug deliv. 2019;26:1140\u201354. https:\/\/doi.org\/10.1080\/10717544.2019.1686087.","DOI":"10.1080\/10717544.2019.1686087"},{"key":"560_CR46","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3390\/ph16121680","volume":"16","author":"S Zolghadri","year":"2023","unstructured":"Zolghadri S, Asad AG, Farzi F, Ghajarzadeh F, Habibi Z, Rahban M, Zolghadri S, Stanek A. Span 60\/Cholesterol niosomal formulation as a suitable vehicle for gallic acid delivery with potent in vitro antibacterial, antimelanoma, and anti-tyrosinase activity. Pharmaceuticls. 2023;16:1680. https:\/\/doi.org\/10.3390\/ph16121680.","journal-title":"Pharmaceuticls"},{"key":"560_CR47","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1016\/j.xphs.2021.07.017","volume":"110","author":"ME Halawany","year":"2021","unstructured":"Halawany ME, Latif R, Badawi A. The potential of a site-specific delivery of thiamine hydrochloride as a novel insect repellent exerting long-term protection on human skin: in-vitro, ex-vivo study and clinical assessment. J Pharm Sci. 2021;110:3659\u201369.","journal-title":"J Pharm Sci"},{"key":"560_CR48","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.colsurfb.2012.10.055","volume":"103","author":"A Ribeiro","year":"2013","unstructured":"Ribeiro A, Sandez-Macho I, Casas M, Alvarez-Perez S, Alvarez-Lorenzo C, Concheiro A. Poloxamine micellar solubilization of alpha-tocopherol for topical ocular treatment. Colloids Surf B Biointerfaces. 2013;103:550\u20137. https:\/\/doi.org\/10.1016\/j.colsurfb.2012.10.055.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"560_CR49","doi-asserted-by":"publisher","first-page":"12044","DOI":"10.1021\/la302310y","volume":"28","author":"JS Nambam","year":"2012","unstructured":"Nambam JS, Philip J. Thermogelling Properties of Triblock Copolymers in the Presence of Hydrophilic Fe3O4 Nanoparticles and Surfactants. Langmuir. 2012;28:12044\u201353. https:\/\/doi.org\/10.1021\/la302310y.","journal-title":"Langmuir"},{"key":"560_CR50","first-page":"2963","volume":"8","author":"T Mukhopadhyay","year":"2002","unstructured":"Mukhopadhyay T, Sasaki J-i, Ramesh R, Roth JA. Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo. Clin Cancer Res. 2002;8:2963\u20139.","journal-title":"Clin Cancer Res"},{"key":"560_CR51","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-1-59745-210-6_10","volume":"437","author":"Y Shen","year":"2008","unstructured":"Shen Y, Tang H, Radosz M, Van Kirk E, Murdoch WJ. pH-responsive nanoparticles for cancer drug delivery. Methods Mol Biol. 2008;437:183\u2013216. https:\/\/doi.org\/10.1007\/978-1-59745-210-6_10.","journal-title":"Methods Mol Biol"},{"key":"560_CR52","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.clinbiochem.2004.05.003","volume":"37","author":"S Holdenrieder","year":"2004","unstructured":"Holdenrieder S, Stieber P. Apoptotic markers in cancer. Clin Biochem. 2004;37:605\u201317. https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.05.003.","journal-title":"Clin Biochem"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-025-00560-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-025-00560-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-025-00560-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T13:03:17Z","timestamp":1745586197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-025-00560-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["560"],"URL":"https:\/\/doi.org\/10.1007\/s40199-025-00560-3","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interests"}}],"article-number":"17"}}